CHICAGO, Sept. 2 (UPI) -- Two studies say brachytherapy -- radiation seed implants -- is a superior treatment for early-stage prostate cancer, officials at a Chicago non-profit say.
PHILADELPHIA, Jan. 1 (UPI) -- U.S. scientists have found a protein that seems key to turning on a recurrent prostate cancer that is resistant to hormone therapy.
BUFFALO, N.Y., April 17 (UPI) -- A U.S. study suggests selenium might offer an intervention strategy for the treatment of prostate cancer.
DENVER, June 26 (UPI) -- U.S. men diagnosed with prostate cancer made initial treatment decisions based on fear and uncertainty and had little interest in second opinions.
WASHINGTON, Aug. 15 (UPI) -- Testing for an activated Stat5 protein in prostate tumors predicts whether the cancer will become more aggressive and life threatening, U.S. researchers say.
MINNEAPOLIS, April 1 (UPI) -- U.S. researchers said men who have radiation therapy for prostate cancer have a 70 percent higher risk of rectal cancer than men who have surgery instead.
SEATTLE, Aug. 23 (UPI) -- U.S. scientists have discovered a key driver behind the progression of prostate cancer that could be targeted for future treatments.
ROCKVILLE, Md., Dec. 2 (UPI) -- A new U.S. government study recommended Monday that physicians not test men routinely for prostate cancer because the public health benefit of such testing has not been established.
GRENOBLE, France, July 11 (UPI) -- Suppressing a male hormone associated with prostate cancer could increase an advanced prostate cancer patient's chances of living free of the disease substantially, but the therapy comes with some strong side effects, researchers report.
DURHAM, N.C., Jan. 30 (UPI) -- A new study in its early phase suggests a cancer vaccine made with prostate cancer patients' own cells is safe and effectively triggers an immune system attack on the tumor. Dr. Johannes Vieweg of Duke University Medical Center tested the experimental vac
